Eva Venegas-Moreno

发表

Surgical Outcomes and Comorbidities in Cushing Disease: 30 Years of Experience in a Referral Center.

A. Soto-Moreno, D. Cano, Elena Dios, 2019, World neurosurgery.

Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features

R. Luque, Noelia Gros-Herguido, P. Remón-Ruíz, 2020, Journal of clinical medicine.

Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly

M. Balcerzyk, R. Leal-Campanario, R. Luque, 2015, Scientific Reports.

E‐cadherin expression is associated with somatostatin analogue response in acromegaly

R. Luque, A. Soto-Moreno, J. Castaño, 2019, Journal of cellular and molecular medicine.

A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report

Elena Fajardo, P. Remón-Ruíz, A. Soto-Moreno, 2021, Frontiers in Endocrinology.

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas

R. Kineman, M. Culler, R. Luque, 2017, Scientific Reports.

Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and -independent mechanisms.

R. Luque, A. Soto-Moreno, J. Castaño, 2019, The Journal of clinical endocrinology and metabolism.

The Molecular Registry of Pituitary Adenomas (REMAH): A bet by Spanish Endocrinology for the future of individualized medicine and translational research

S. Gaztambide, M. Puig-Domingo, M. Marazuela, 2016 .

The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.

S. Gaztambide, M. Puig-Domingo, M. Marazuela, 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly

R. Luque, Noelia Gros-Herguido, A. Soto-Moreno, 2017, Journal of cellular and molecular medicine.

Integrative clinical, radiological and molecular analysis for predicting remission and recurrence of Cushing's disease.

C. Lamas, R. Luque, P. Remón-Ruíz, 2022, The Journal of clinical endocrinology and metabolism.

Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas.

R. Kineman, L. Kasuki, M. Gadelha, 2015, Cancer letters.

Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics

Elena Fajardo, E. Rivas, A. Martínez-Ortega, 2022, Journal of clinical medicine.

Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain

S. Gaztambide, F. Cordido, A. Soto-Moreno, 2020, Neuroendocrinology.

Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly

A. Soto-Moreno, J. F. Martin-Rodriguez, D. Cano, 2013, PloS one.

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center

V. Bours, A. Soto-Moreno, A. Beckers, 2019, Endocrine connections.

Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors

M. Korbonits, M. Branco, R. Luque, 2021, Molecular oncology.

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features

L. Kasuki, M. Gadelha, R. Luque, 2019, Cancers.

A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells

M. Culler, R. Luque, A. Soto-Moreno, 2019, Neuroendocrinology.

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.

M. Arráez, R. Luque, A. Soto-Moreno, 2016, The Journal of endocrinology.

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features

M. Culler, C. Diéguez, R. Luque, 2015, Scientific Reports.

Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.

A. Leon-Justel, R. Luque, A. Soto-Moreno, 2014, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications.

R. Luque, A. Soto-Moreno, J. Castaño, 2013, The Journal of clinical endocrinology and metabolism.

Our experience in prolactinomas larger than 60mm.

Elena Fajardo, P. Remón-Ruíz, A. Soto-Moreno, 2020, Endocrinologia, diabetes y nutricion.

Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors

R. Kineman, R. Granata, R. Luque, 2020, Neuroendocrinology.

A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

M. Culler, Shengwen Zhang, R. Luque, 2019, Clinical Cancer Research.

Description of characteristics and outcomes of a cohort of patients with severe and enduring eating disorders (SE-ED)

P. Remón-Ruíz, A. Soto-Moreno, Antonio J. Vázquez-Morejón, 2021, Journal of eating disorders.